Master License Agreement

Seeing Machines Limited
29 June 2007


                                       


29 June 2007

                            Seeing Machines Limited

                      ('Seeing Machines' or the 'Company')



SEEING MACHINES AND THE AUSTRALIAN NATIONAL UNIVERSITY SIGN MASTER DEVELOPMENT &
                          COMMERCIALIZATION AGREEMENT


Seeing Machines (AIM: SEE), a leading developer of advanced computer based
imaging software systems, announces today that it has concluded a master
development and commercialization agreement with the Australian National
University (ANU).


Under the terms of the agreement Seeing Machines will provide material support
to the research efforts of the ANU through the loan of materials, software,
equipment and know-how. In return Seeing Machines acquires the first rights to
commercialize all intellectual property generated by the research activities
conducted within the ANU and supported by the materials.


Dr Fiona Nelms, Director of the Office of Commercialisation at the ANU
commented: 'This agreement furthers the strong relationship between ANU and
Seeing Machines with an aim to develop state of the art diagnostic tools for
glaucoma and other eye diseases. Our collaboration to date has enabled ANU IP to
develop in a commercial setting thereby increasing the chance of successful
product development, and we look forward to building on this with the execution
of this new agreement.'


Nick Cerneaz CEO of Seeing Machines said: 'This agreement cements the strong
foundation that has been established between the Company and the University over
the last few years. We have worked very closely with the world class team at the
Research School of Biological Sciences at ANU for the development of the
TrueField Analyzer, and we are tremendously excited about the pipeline of future
applications that can be built on that base platform. There are already a number
of research activities underway within the University that are supported by
materials from Seeing Machines and come under the scope of this agreement, and
we look forward to realizing the potential of that work in the future.'


Further information about Seeing Machines can be obtained from the company
website www.seeingmachines.com.


                                  --- ENDS ---


Enquiries:
Seeing Machines Limited   Insinger de Beaufort     Parkgreen Communications
Nick Cerneaz, CEO         Peter Ward               Clare Irvine
[phone]       [phone]     [phone]
www.seeingmachines.com


Notes to editors:



About Seeing Machines


Seeing Machines is an award winning Technology Company which focuses on vision
based human machine interfaces. Formed in 2000 in Canberra, Australia, Seeing
Machines' purpose is to commercialise its computer-vision across a range of
industries and applications.

Seeing Machines deliver advanced computer vision solutions for researches and
developers in human factors, transportation safety, computer human interaction,
robotics, medical research and psychology. The flagship product faceLAB(R)
provides an automated and contact-free gaze and head tracking technology, it
solves the problem of observing human behaviour naturally, non-intrusively and
with a high degree of accuracy and usability. Building on these unique face
tracking and pupil measurement and monitoring capabilities, the TrueField
Analyzer(R) is a development undertaken by Seeing Machines in partnership with
colleagues from the Research School of Biological Sciences (RSBS) at the
Australian National University (ANU).

The TrueField Analyzer(R) offers a new objective method to help doctors diagnose
and manage a range of eye diseases including glaucoma, age related macular
degeneration and diabetic retinopathy. Glaucoma affects about 2-3% of the
population over 40 years of age and is a leading source of blindness. Unlike
most other devices available to the clinician the TrueField Analyzer is a
completely objective test and it is quick and easy for patients and technicians
alike. The device measures both eyes concurrently and due to the reliability
that arises from the objective nature of the test, it has the potential to
become a new standard in the measurement of visual field defects and thus in the
diagnosis and management of disease such as glaucoma.

More generally Seeing Machines' computer vision systems are able to measure the
orientation and position of a human head, estimate eye-gaze direction, detect
eye blinks and track other facial features. This functionality is achieved
entirely though visual means, using video cameras connected to advanced image
processing software, with no attachments required on the subject. Products such
as faceLAB(R) are designed to allow human factors researchers and designers to
assess the interaction of an operator in an environment and this finds
application in designing operator environments, such as cockpits for cars,
trucks, trains, and aeroplanes for instance, and other industrial design
applications, as well as medical and psychological research situations. The
technology also has application in monitoring automobile drivers and if it
detects drowsiness or that the driver is distracted and their attention has been
diverted from the road, an alarm can be raised to alert the driver to either
pull over and rest in the case of drowsiness or to pay more attention to the
road.

The systems work in real-time, enabling the behaviour of subjects to be tracked
in real-time. This technology is paving the way in promoting safer driving
conditions and works to enhance the driving experience and to eliminate
accidents caused through driver drowsiness or distraction.

There are many different sectors that can benefit from this revolutionary
software, for which it has been developed, including: automotive; academic
research; medicine/healthcare; defence; autostereoscopy (next generation
displays); sport; and games.



                      This information is provided by RNS
            The company news service from the London Stock Exchange